- Home
- DIBS vs ENTX Comparison
DIBS vs ENTX Comparison
Compare DIBS & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- ENTX
- Stock Information
- Founded
- DIBS 2000
- ENTX 2010
- Country
- DIBS United States
- ENTX Israel
- Employees
- DIBS 284
- ENTX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIBS Consumer Discretionary
- ENTX Health Care
- Exchange
- DIBS Nasdaq
- ENTX Nasdaq
- Market Cap
- DIBS 86.4M
- ENTX 69.6M
- IPO Year
- DIBS 2021
- ENTX 2018
- Fundamental
- Price
- DIBS $2.45
- ENTX $1.79
- Analyst Decision
- DIBS Hold
- ENTX Strong Buy
- Analyst Count
- DIBS 1
- ENTX 1
- Target Price
- DIBS N/A
- ENTX $10.00
- AVG Volume (30 Days)
- DIBS 123.8K
- ENTX 30.9K
- Earning Date
- DIBS 05-09-2025
- ENTX 05-09-2025
- Dividend Yield
- DIBS N/A
- ENTX N/A
- EPS Growth
- DIBS N/A
- ENTX N/A
- EPS
- DIBS N/A
- ENTX N/A
- Revenue
- DIBS $88,257,000.00
- ENTX $181,000.00
- Revenue This Year
- DIBS $5.47
- ENTX N/A
- Revenue Next Year
- DIBS $6.46
- ENTX N/A
- P/E Ratio
- DIBS N/A
- ENTX N/A
- Revenue Growth
- DIBS 4.22
- ENTX N/A
- 52 Week Low
- DIBS $2.30
- ENTX $1.41
- 52 Week High
- DIBS $6.20
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- DIBS 31.53
- ENTX 49.59
- Support Level
- DIBS $2.33
- ENTX $1.50
- Resistance Level
- DIBS $2.49
- ENTX $1.84
- Average True Range (ATR)
- DIBS 0.20
- ENTX 0.11
- MACD
- DIBS -0.00
- ENTX 0.03
- Stochastic Oscillator
- DIBS 17.34
- ENTX 85.50
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.